Stay updated on ADXS-503 & Pembro in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.

Latest updates to the ADXS-503 & Pembro in Lung Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision history updated to include v3.5.2 and remove v3.5.0.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision: v3.4.3 is now shown, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.4.2; removed the previous government funding/operating-status notice and Revision: v3.4.1.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a government funding lapse notice banner about NIH operations and a new revision tag (v3.4.1); the previous revision tag (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check89 days agoChange DetectedShow glossary toggle is now visible and two metadata labels have updated capitalization (Last Update Submitted that Met QC Criteria; No FEAR Act Data). The revision label has changed from v3.3.4 to v3.4.0, indicating a minor update.SummaryDifference0.2%

Stay in the know with updates to ADXS-503 & Pembro in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.